106 related articles for article (PubMed ID: 33362171)
1. Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients.
Marino D; Baratelli C; Guida G; Turco CGC; Lacidogna G; Sperti E; Vignani F; De Luca E; Zichi C; Audisio M; Ballaminut D; Bellezza A; Chiotto P; Ciriolo G; Comite R; Codegone F; Florio S; Fusco L; Polimeno L; Pozzi D; Zilio E; Terzolo S; Di Maio M
Recenti Prog Med; 2020 Dec; 111(12):740-748. PubMed ID: 33362171
[TBL] [Abstract][Full Text] [Related]
2. The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life.
Baratelli C; Turco CGC; Lacidogna G; Sperti E; Vignani F; Marino D; Zichi C; De Luca E; Audisio M; Ballaminut D; Bellezza A; Chiotto P; Ciriolo G; Comite R; Codegone F; Florio S; Fusco L; Polimeno L; Pozzi D; Zilio E; Terzolo S; Di Maio M
Support Care Cancer; 2019 Dec; 27(12):4697-4704. PubMed ID: 30949832
[TBL] [Abstract][Full Text] [Related]
3. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
Quinten C; Maringwa J; Gotay CC; Martinelli F; Coens C; Reeve BB; Flechtner H; Greimel E; King M; Osoba D; Cleeland C; Ringash J; Schmucker-Von Koch J; Taphoorn MJ; Weis J; Bottomley A
J Natl Cancer Inst; 2011 Dec; 103(24):1851-8. PubMed ID: 22157640
[TBL] [Abstract][Full Text] [Related]
4. Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.
Pittet VEH; Maillard MH; Simonson T; Fournier N; Rogler G; Michetti P;
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2050-2059.e1. PubMed ID: 30471455
[TBL] [Abstract][Full Text] [Related]
5. Disagreement between patient- and physician-reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
Ooki A; Morita S; Tsuji A; Iwamoto S; Hara H; Tanioka H; Satake H; Kataoka M; Kotaka M; Kagawa Y; Nakamura M; Shingai T; Ishikawa M; Miyake Y; Suto T; Hashiguchi Y; Yabuno T; Ando M; Sakamoto J; Yamaguchi K
Cancer Med; 2020 Dec; 9(24):9419-9430. PubMed ID: 33222406
[TBL] [Abstract][Full Text] [Related]
6. The perception gap of chemotherapy-induced adverse events between doctors and cancer patients: an observational study in China.
Yu J; Zhang Z; Zhou H; Liu X; Huang Y; Fang W; Yang Y; Hong S; Zhou T; Zhang Y; Chen G; Zhao S; Zhang Z; Ma Y; Zhao H; Gao R; Zhang L
Support Care Cancer; 2021 Mar; 29(3):1543-1548. PubMed ID: 32728801
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial.
Trojan A; Leuthold N; Thomssen C; Rody A; Winder T; Jakob A; Egger C; Held U; Jackisch C
J Med Internet Res; 2021 Aug; 23(8):e29271. PubMed ID: 34383675
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.
Di Maio M; Gallo C; Leighl NB; Piccirillo MC; Daniele G; Nuzzo F; Gridelli C; Gebbia V; Ciardiello F; De Placido S; Ceribelli A; Favaretto AG; de Matteis A; Feld R; Butts C; Bryce J; Signoriello S; Morabito A; Rocco G; Perrone F
J Clin Oncol; 2015 Mar; 33(8):910-5. PubMed ID: 25624439
[TBL] [Abstract][Full Text] [Related]
9. Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.
Montemurro F; Mittica G; Cagnazzo C; Longo V; Berchialla P; Solinas G; Culotta P; Martinello R; Foresto M; Gallizioli S; Calori A; Grasso B; Volpone C; Bertola G; Parola G; Tealdi G; Giuliano PL; Aglietta M; Ballari AM
JAMA Oncol; 2016 Apr; 2(4):445-52. PubMed ID: 26720497
[TBL] [Abstract][Full Text] [Related]
10. Low Concordance of Patient-Reported Outcomes With Clinical and Clinical Trial Documentation.
Fares CM; Williamson TJ; Theisen MK; Cummings A; Bornazyan K; Carroll J; Spiegel ML; Stanton AL; Garon EB
JCO Clin Cancer Inform; 2018 Dec; 2():1-12. PubMed ID: 30652613
[TBL] [Abstract][Full Text] [Related]
11. Concordance between patient-reported and physician-documented comorbidities and symptoms among Stage 4 breast cancer patients.
Umashankar S; Basu A; Esserman L; Van't Veer L; Melisko ME
Cancer Med; 2023 Nov; 12(22):20906-20917. PubMed ID: 37902219
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes collected in ambulatory oncology practices: Feasibility, patterns, and correlates.
Friese CR; Fauer AJ; Kuisell C; Mendelsohn-Victor K; Wright NC; Griggs JJ; Manojlovich M
Health Serv Res; 2020 Dec; 55(6):966-972. PubMed ID: 33125170
[TBL] [Abstract][Full Text] [Related]
13. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
14. Patient-Reported Outcomes vs. Clinician Symptom Reporting During Chemoradiation for Rectal Cancer.
Flores LT; Bennett AV; Law EB; Hajj C; Griffith MP; Goodman KA
Gastrointest Cancer Res; 2012 Jul; 5(4):119-24. PubMed ID: 23077685
[TBL] [Abstract][Full Text] [Related]
15. Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire.
Cirillo M; Venturini M; Ciccarelli L; Coati F; Bortolami O; Verlato G
Ann Oncol; 2009 Dec; 20(12):1929-35. PubMed ID: 19622510
[TBL] [Abstract][Full Text] [Related]
16. Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study.
Thiery-Vuillemin A; Poulsen MH; Lagneau E; Ploussard G; Birtle A; Dourthe LM; Beal-Ardisson D; Pintus E; Trepiakas R; Lefresne F; Lukac M; Van Sanden S; Pissart G; Reid A;
Eur Urol; 2020 Mar; 77(3):380-387. PubMed ID: 31594705
[TBL] [Abstract][Full Text] [Related]
17. Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain.
Wirz S; Wartenberg HC; Nadstawek J
Support Care Cancer; 2008 Sep; 16(9):999-1009. PubMed ID: 18095008
[TBL] [Abstract][Full Text] [Related]
18. PROutine: a feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer.
Benze G; Nauck F; Alt-Epping B; Gianni G; Bauknecht T; Ettl J; Munte A; Kretzschmar L; Gaertner J
Ann Palliat Med; 2019 Apr; 8(2):104-111. PubMed ID: 29156896
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
[TBL] [Abstract][Full Text] [Related]
20. Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice.
Hubbard JM; Grothey AF; McWilliams RR; Buckner JC; Sloan JA
J Oncol Pract; 2014 Jul; 10(4):248-53. PubMed ID: 24667294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
